EVALUATION OF IMMUNOGENICITY AND PTOTECTIVENESS OF THE VACCINIA VIRUS LIVP-GFP IN THREE LABORATORY ANIMAL SPECIES

por S. Shchelkunov, A. Sergeev, S. Yakubitskyi, K. Titova, S. Pyankov
Publicado 2019

RHEUMATOID ARTHRITIS: LABORATORY MODELS OF THE DISEASE

por I. A. Orlovskaya, D. D. Tsyrendorzhiev, S. N. Shchelkunov
Publicado 2015

Obtainingvaccinia virus with increased production of extracellular enveloped virions and directing GM-CSF synthesis as a promising basis for development of antitumor drug

por T. V. Bauer, T. V. Tregubchak, S. N. Shchelkunov, R. A. Maksyutov, E. V. Gavrilova
Publicado 2020

Route-coupled pathogenicity and immunogenicity of vaccinia virus variant inoculated mice

por S. N. Shchelkunov, A. A. Sergeev, A. S. Kabanov, S. N. Yakubitskyi, T. V. Bauer, S. A. Pyankov
Publicado 2021

A New Class of Uracil–DNA Glycosylase Inhibitors Active against Human and Vaccinia Virus Enzyme

por Inga R. Grin, Grigory V. Mechetin, Rustem D. Kasymov, Evgeniia A. Diatlova, Anna V. Yudkina, Sergei N. Shchelkunov, Irina P. Gileva, Alexandra A. Denisova, Grigoriy A. Stepanov, Ghermes G. Chilov, Dmitry O. Zharkov
Publicado 2021